148 related articles for article (PubMed ID: 1720830)
1. Contribution of spinal dopamine receptors to the hypotensive action of bromocriptine in rats.
Lahlou S; Demenge P
J Cardiovasc Pharmacol; 1991 Sep; 18(3):317-25. PubMed ID: 1720830
[TBL] [Abstract][Full Text] [Related]
2. Increase in the hypotensive effect of bromocriptine induced by spinal transection in rats: contribution of spinal dopamine receptors.
Lahlou S; Demenge P
J Cardiovasc Pharmacol; 1992 May; 19(5):723-31. PubMed ID: 1381770
[TBL] [Abstract][Full Text] [Related]
3. Hypotensive action of bromocriptine in the DOCA-salt hypertensive rat: contribution of spinal dopamine receptors.
Lahlou S; Duarte GP
Fundam Clin Pharmacol; 1998; 12(6):599-606. PubMed ID: 9917201
[TBL] [Abstract][Full Text] [Related]
4. Neuronal and postjunctional components in the blood pressure effects of dopamine and bromocriptine in rabbits.
Ensinger H; Majewski H; Hedler L; Starke K
J Pharmacol Exp Ther; 1985 Sep; 234(3):681-90. PubMed ID: 2993590
[TBL] [Abstract][Full Text] [Related]
5. Central bromocriptine-induced tachycardia is reversed to bradycardia in conscious, deoxycorticosterone acetate-salt hypertensive rats.
Lahlou S
Pharmacol Toxicol; 2001 May; 88(5):238-43. PubMed ID: 11393583
[TBL] [Abstract][Full Text] [Related]
6. Involvement of spinal dopamine receptors in mediation of the hypotensive and bradycardic effects of systemic quinpirole in anaesthetised rats.
Lahlou S
Eur J Pharmacol; 1998 Jul; 353(2-3):227-37. PubMed ID: 9726652
[TBL] [Abstract][Full Text] [Related]
7. Blood pressure lowering effects of N,N-di-n-propyl-dopamine in rats: evidence for stimulation of peripheral dopamine receptors leading to inhibition of sympathetic vascular tone.
Cavero I; Lefèvre-Borg F; Gomeni R
J Pharmacol Exp Ther; 1981 Aug; 218(2):515-24. PubMed ID: 7252851
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular effects of bromocriptine in rats: role of peripheral adrenergic and dopaminergic receptors.
Roquebert J; Alaoui K; Morán Benito A
J Auton Pharmacol; 1990 Apr; 10(2):85-96. PubMed ID: 2161850
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological, hemodynamic and autonomic nervous system mechanisms responsible for the blood pressure and heart rate lowering effects of pergolide in rats.
Cavero I; Lefevre-Borg F; Lhoste F; Sabatier C; Richer C; Giudicelli JF
J Pharmacol Exp Ther; 1984 Mar; 228(3):779-91. PubMed ID: 6707926
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular responses to intrathecal dopamine receptor agonists in conscious DOCA-salt hypertensive rats.
Lahlou S
Fundam Clin Pharmacol; 1999; 13(6):624-34. PubMed ID: 10626749
[TBL] [Abstract][Full Text] [Related]
11. Central dopaminergic origin of bromocriptine induced tachycardia in normotensive rats.
Lahlou S; Duarte GP; Demenge P
Cardiovasc Res; 1993 Nov; 27(11):2022-7. PubMed ID: 8287413
[TBL] [Abstract][Full Text] [Related]
12. Hypotensive and bradycardic effects elicited by spinal dopamine receptor stimulation: effects of D1 and D2 receptor agonists and antagonists.
Pellissier G; Demenge P
J Cardiovasc Pharmacol; 1991 Oct; 18(4):548-55. PubMed ID: 1724532
[TBL] [Abstract][Full Text] [Related]
13. Selective antagonism of the hypotensive effects of dopamine agonists in spontaneously hypertensive rats.
McCoy CE; Douglas FL; Goldberg LI
Hypertension; 1986 Apr; 8(4):298-302. PubMed ID: 2870024
[TBL] [Abstract][Full Text] [Related]
14. Hypotensive action and alpha-adrenolytic properties of a new dopaminergic agonist, CU 32-085, in the rat.
Morales-Olivas FJ; Palop V; Rubio E; Esplugues J
Arch Int Pharmacodyn Ther; 1984 Nov; 272(1):71-8. PubMed ID: 6151381
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular effects in the rat of intrathecal injections of apomorphine at the thoracic spinal cord level.
Petitjean P; Mouchet P; Pellissier G; Manier M; Feuerstein C; Demenge P
Eur J Pharmacol; 1984 Oct; 105(3-4):355-9. PubMed ID: 6548972
[TBL] [Abstract][Full Text] [Related]
16. Identification of dopamine receptor subtypes in the hypotensive action of SK&F 85174 in anesthetized rats.
Sowinski BA; Lokhandwala MF
J Auton Pharmacol; 1987 Jun; 7(2):105-9. PubMed ID: 2888767
[TBL] [Abstract][Full Text] [Related]
17. Activation of spinal metabotropic glutamate receptors elicits cardiovascular responses in pentobarbital anesthetized rats.
Celuch SM; García Mdel C
Naunyn Schmiedebergs Arch Pharmacol; 2002 Oct; 366(4):343-9. PubMed ID: 12237748
[TBL] [Abstract][Full Text] [Related]
18. Involvement of peripheral dopamine receptors in the antihypertensive effect of a new ergoline derivative (355/1057).
Salvati P; Bianchi G
Arch Int Pharmacodyn Ther; 1985 Apr; 274(2):291-304. PubMed ID: 4026460
[TBL] [Abstract][Full Text] [Related]
19. Blunted pressor responsiveness to intravenous quinpirole in conscious, chronic spinal cord-transected rats: peripheral vs. spinal mechanisms.
Lahlou S
Eur J Pharmacol; 2000 Nov; 408(1):51-62. PubMed ID: 11070183
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular characterization of the DA2 dopamine receptor agonist quinpirole in rats.
Lefevre-Borg F; Lorrain J; Lechaire J; Thiry C; Lhoste F; Hicks PE; Cavero I
Fundam Clin Pharmacol; 1987; 1(3):179-200. PubMed ID: 2892767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
